• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阻塞性心肌病中的人类白细胞抗原-DRw分型]

[HLA-DRW grouping in obstructive myocardiopathy].

作者信息

Becqué O, Bernard Y, Bassand J P, Hervé P, Maurat J P

出版信息

Arch Mal Coeur Vaiss. 1984 Nov;77(12):1359-62.

PMID:6439160
Abstract

Hypertrophic myocardiopathy with obstruction (HOMC) is a disease of unknown aetiology with a high familial incidence. This study was undertaken to determine its relationship to the HLA system, as proved in a number of other conditions. The clinical suspicion of HOMC was confirmed in all cases by echocardiography. In addition, 4 patients were also catheterised, confirming the presence of an intraventricular pressure gradient. One patient was investigated after surgery. None of the patients was hypertensive. In two cases, a positive family history of HOMC confirmed the hereditary nature of the condition. The HLA-A and B grouping was performed by the micro-lymphocytotoxic technique. The HLA-DRW was carried out with B lymphocytes separated either by column filtration or by rosetting on a Ficoll gradient. We did not find a statistically significant prevalence of any of the antigens tested on the A, B on DRW loci. Our results were compared with previously published data. They support the findings of Bloch et al. in a genetically comparable study population (HLA A and B only) but contradict those of Matsumori (oriental population). We were unable to demonstrate a liaison between antigens of the HLA system and HOMC. However, as was shown in our study, HLA grouping is valuable in familial forms of HOMC (mechanism of transmission, detection of clinically latent forms).

摘要

梗阻性肥厚型心肌病(HOMC)是一种病因不明、家族发病率高的疾病。本研究旨在确定其与HLA系统的关系,这在许多其他疾病中已得到证实。所有病例均通过超声心动图确诊为临床疑似的HOMC。此外,4例患者还进行了心导管检查,证实存在心室内压力梯度。1例患者在手术后接受了检查。所有患者均无高血压。2例患者有HOMC家族史阳性,证实了该病的遗传性。HLA - A和B分型采用微量淋巴细胞毒技术进行。HLA - DRW分型是用通过柱过滤或在Ficoll梯度上进行玫瑰花结分离的B淋巴细胞进行的。我们没有发现在A、B或DRW位点上所检测的任何抗原存在统计学上的显著流行率。我们的结果与先前发表的数据进行了比较。它们支持了Bloch等人在遗传上可比的研究人群(仅HLA - A和B)中的发现,但与Matsumori(东方人群)的结果相矛盾。我们无法证明HLA系统的抗原与HOMC之间存在关联。然而,正如我们的研究所表明的,HLA分型在家族性HOMC形式中具有重要价值(传播机制、临床潜伏形式的检测)。

相似文献

1
[HLA-DRW grouping in obstructive myocardiopathy].[阻塞性心肌病中的人类白细胞抗原-DRw分型]
Arch Mal Coeur Vaiss. 1984 Nov;77(12):1359-62.
2
[Occurrence of HLA-antigens in patients with hypertrophic cardiomyopathy].[肥厚型心肌病患者中 HLA 抗原的出现情况]
Z Kardiol. 1982 Dec;71(12):820-3.
3
[Genetic aspects of hypertrophic cardiomyopathy (familial studies and relation of HLA to obstructive hypertrophic cardiomyopathy)].
Ter Arkh. 1987;59(8):82-5.
4
An immunogenetic study in hypertrophic cardiomyopathy.肥厚型心肌病的免疫遗传学研究。
Cor Vasa. 1991;33(5):414-23.
5
[Immunogenetic study in hypertrophic cardiomyopathy].肥厚型心肌病的免疫遗传学研究
Vnitr Lek. 1992 May;38(5):466-72.
6
[Hypertrophic cardiomyopathy occurring in the family. Rare coexistence with oligophrenia. Clinical examinations, cytogenetic and HLA system].[家族性肥厚型心肌病。与智力发育不全罕见并存。临床检查、细胞遗传学及 HLA 系统]
Kardiol Pol. 1993 Aug;39(8):84-9; discussion 90.
7
[Lack of correlation between HLA haplotypes and familial hypertrophic cardiomyopathy].
G Ital Cardiol. 1985 Apr;15(4):384-6.
8
[HLA antigens in patients with primary cardiomyopathy].[原发性心肌病患者的人类白细胞抗原(HLA)抗原]
Kardiol Pol. 1988;31(9):598-604.
9
HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.卡普兰综合征中的HLA - A、B和DR抗原以及备解素因子B同种异型
Br J Dis Chest. 1983 Jul;77(3):235-42.
10
Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.人类淋巴细胞-DR2抗原与日本溃疡性结肠炎的关联。
Gastroenterology. 1982 Mar;82(3):413-8.

引用本文的文献

1
Hypertrophic obstructive cardiomyopathy in rheumatoid arthtritis - coincidence or association? A case report.类风湿关节炎合并肥厚性梗阻性心肌病——巧合还是关联?一例病例报告。
Exp Clin Cardiol. 2009 Spring;14(1):e21-2.